FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/21/2023
Back to search
Official data from USPTO
PHARMABIOME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMABIOME
ST13
US500000079318582Class
5, 42, 44
Filing
79318582
Registration
7002506
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
07/21/2023
Trademark type
Word
Nice classes
5, 42, 44
Filing date
07/02/2021
Registration date
03/21/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/21/2023
Last transaction
03/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
LEE, DOUGLAS
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PharmaBiome AG
Representatives
Erica Halstead Womble Bond Dickinson (US) LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productsmedical and veterinary preparations used to maintain health or restore health to a human or an animal subject via treatment of a disturbed microbial community; pharmaceutical or biopharmaceutical agents in the nature of microorganisms for preventing or treating human and animal diseasenamely infectious diseaseautoimmune diseaseinflammatory diseaseimmune disordersallergic disorderscancerimmune-oncologymetabolic disordersdigestive disordersneurological disorders and cardiovascular disorders; dietetic substances and foodstuffsnutritional supplements and additives for medical or veterinary purposes; nutritive substances for microorganisms for medical and veterinary purposes
Class 42
Scientific research and technology consultation in the field of microorganisms and cells; development of pharmaceuticalsnamely microbiologics and immunotherapeuticsfor preventing or treating disease associated with a disturbed microbial community; industrial analysis and industrial research in the field of microorganisms and cells; research and development of technology services in the field of food additivesdietary supplementsmedical foodsfor the diagnosisprevention and treatment of human and animal diseases; design and development of computer software
Class 44
Medical services; veterinary services; consulting services in the fields of diagnostic medical testing and nutrition; services of medical diagnostic testingmonitoringreporting relating to a microbial community
Publications
History of USPTO decisions and trademark events.
31 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/28/2023
FIMP
FINAL DISPOSITION PROCESSED
06/27/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/21/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/21/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/21/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/20/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/01/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/01/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/03/2023
PUBO
PUBLISHED FOR OPPOSITION
01/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/14/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/23/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/09/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/08/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/08/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/18/2022
GNFR
FINAL REFUSAL E-MAILED
10/18/2022
CNFR
FINAL REFUSAL WRITTEN
10/18/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/14/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/14/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/14/2022
RFNT
REFUSAL PROCESSED BY IB
05/30/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/10/2022
RFRR
REFUSAL PROCESSED BY MPU
05/09/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/29/2022
CNRT
NON-FINAL ACTION WRITTEN
03/28/2022
DOCK
ASSIGNED TO EXAMINER
03/24/2022
MAFR
APPLICATION FILING RECEIPT MAILED
08/31/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/27/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/26/2021
Continuous trademark protection
Get notified about every new filing that threatens PHARMABIOME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.